IDEXX Laboratories Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for IDEXX Laboratories stock have an average target of 533.75, with a low estimate of 500 and a high estimate of 580. The average target predicts an increase of 27.66% from the current stock price of 418.11.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$500	$533.75	$535	$580
Change	+19.59%	+27.66%	+27.96%	+38.72%

* Price targets were last updated on Feb 10, 2025.

Analyst Ratings

The average analyst rating for IDEXX Laboratories stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	2	2	1	1	1
Buy	3	3	4	4	4	4
Hold	2	2	2	2	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	8	7	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Westenberg Piper Sandler	Piper Sandler	Hold Maintains $435 → $510	Hold	Maintains	$435 → $510	+21.98%	Feb 10, 2025
Balaji Prasad Barclays	Barclays	Buy Maintains $481 → $520	Buy	Maintains	$481 → $520	+24.37%	Feb 4, 2025
Michael Ryskin B of A Securities	B of A Securities	Hold Maintains $475 → $535	Hold	Maintains	$475 → $535	+27.96%	Feb 4, 2025
Erin Wright Morgan Stanley	Morgan Stanley	Buy Maintains $559 → $550	Buy	Maintains	$559 → $550	+31.54%	Jan 29, 2025
Daniel Clark Leerink Partners	Leerink Partners	Buy Initiates $500	Buy	Initiates	$500	+19.59%	Dec 2, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

4.20B

from 3.90B

7.76%

from 3.90B

Revenue Next Year

4.54B

from 4.20B

8.05%

from 4.20B

EPS This Year

12.23

from 10.67

14.59%

from 10.67

EPS Next Year

13.86

from 12.23

13.33%

from 12.23

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	2.71B	3.22B	3.37B	3.66B	3.90B	4.20B	4.54B	4.94B
Revenue Growth	12.45%	18.80%	4.73%	8.72%	6.46%	7.76%	8.05%	8.92%
EPS	6.71	8.60	8.03	10.06	10.67	12.23	13.86	15.69
EPS Growth	37.22%	28.17%	-6.63%	25.28%	6.06%	14.59%	13.33%	13.20%
Forward PE	-	-	-	-	-	34.20	30.17	26.66
No. Analysts	-	-	-	-	-	18	18	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	4.4B	4.8B	5.3B
Avg	4.2B	4.5B	4.9B
Low	4.0B	4.3B	4.7B

Revenue Growth

Revenue Growth	2025	2026	2027
High	12.1%	14.1%	16.0%
Avg	7.8%	8.0%	8.9%
Low	2.9%	2.9%	2.9%

EPS Forecast

EPS	2025	2026	2027
High	12.85	14.96	17.18
Avg	12.23	13.86	15.69
Low	11.50	12.80	13.86

EPS Growth

EPS Growth	2025	2026	2027
High	20.4%	22.4%	24.0%
Avg	14.6%	13.3%	13.2%
Low	7.7%	4.7%	0.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.